N-Power Medicine partners with MSD to expand access to oncology clinical trials

 

US-based clinical research company N-Power Medicine has partnered with Merck & Co (MSD) to increase access to clinical trials for oncologists and their patients.

The two companies aim to streamline workflow for clinical research and routine care for patients.

The partnership will make use of N-Power Medicine’s real-time registry and point-of-care platform, which integrates technology, AI and embedded research staff.

It will involve implementing multiple trials in the N-Power Medicine Network, which aims to promote greater physician engagement and provide timely access to clinical trials for eligible patients.

As the network expands, the partners aim to extend this model for clinical development to more oncology indications and cancer centres.

See Also:

• Aerovate slashes workforce after failed Phase IIb trial 

MSD Oncology Clinical Development senior vice-president and head Marjorie Green said: “We look forward to collaborating with N-Power Medicine to leverage their new approach to expanding clinical research to more people with cancer.